|
Lipid and lipoprotein metabolism
Citations 121-130 of 549 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator-Activated Receptor- Activation
- Georg Hansmann, Roger A. Wagner, Stefan Schellong, Vinicio A. de Jesus Perez, Takashi Urashima, Lingli Wang, Ahmad Y. Sheikh, Renée S. Suen, Duncan J. Stewart, and Marlene Rabinovitch
Circulation published March 5, 2007, doi:10.1161/CIRCULATIONAHA.106.663120
[Abstract]
- Vascular Medicine
FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice
- Jerzy-Roch Nofer, Martine Bot, Martin Brodde, Paul J. Taylor, Paul Salm, Volker Brinkmann, Theo van Berkel, Gerd Assmann, and Erik A.L. Biessen
Circulation 2007;115:501-508; published online before print as doi:10.1161/CIRCULATIONAHA.106.641407
[Abstract]
[Full text]
- Basic Science for Clinicians
Peroxisome Proliferator–Activated Receptors as Transcriptional Nodal Points and Therapeutic Targets
- Jonathan D. Brown and Jorge Plutzky
Circulation 2007;115:518-533, doi:10.1161/CIRCULATIONAHA.104.475673
[Abstract]
[Full text]
- Articles
FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
- Jerzy-Roch Nofer, Martine Bot, Martin Brodde, Paul J. Taylor, Paul Salm, Volker Brinkmann, Theo van Berkel, Gerd Assmann, and Erik A.L. Biessen
Circulation published January 22, 2007, doi:10.1161/CIRCULATIONAHA.106.641407
[Abstract]
- AHA Scientific Statements
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
- Rae-Ellen W. Kavey, Vivek Allada, Stephen R. Daniels, Laura L. Hayman, Brian W. McCrindle, Jane W. Newburger, Rulan S. Parekh, and Julia Steinberger
Circulation 2006;114:2710-2738; published online before print as doi:10.1161/CIRCULATIONAHA.106.179568
[Abstract]
[Full text]
- Vascular Medicine
Direct Evidence for a Crucial Role of the Arterial Wall in Control of Atherosclerosis Susceptibility
- Hong Pei, Yinong Wang, Toru Miyoshi, Zhimin Zhang, Alan H. Matsumoto, Gregory A. Helm, George Tellides, and Weibin Shi
Circulation 2006;114:2382-2389; published online before print as doi:10.1161/CIRCULATIONAHA.106.640185
[Abstract]
[Full text]
- Articles
Cardiovascular Risk Reduction in High-Risk Pediatric Patients. A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Endorsed by the American Academy of Pediatrics
- Rae-Ellen W. Kavey, Vivek Allada, Stephen R. Daniels, Laura L. Hayman, Brian W. McCrindle, Jane W. Newburger, Rulan S. Parekh, and Julia Steinberger
Circulation published November 27, 2006, doi:10.1161/CIRCULATIONAHA.106.179568
[Abstract]
- Articles
Direct Evidence for a Crucial Role of the Arterial Wall in Control of Atherosclerosis Susceptibility
- Hong Pei, Yinong Wang, Toru Miyoshi, Zhimin Zhang, Alan H. Matsumoto, Gregory A. Helm, George Tellides, and Weibin Shi
Circulation published November 13, 2006, doi:10.1161/CIRCULATIONAHA.106.640185
[Abstract]
- Vascular Medicine
Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein B
- John J.P. Kastelein, Mark K. Wedel, Brenda F. Baker, John Su, JoAnn D. Bradley, Rosie Z. Yu, Emil Chuang, Mark J. Graham, and Rosanne M. Crooke
Circulation 2006;114:1729-1735; published online before print as doi:10.1161/CIRCULATIONAHA.105.606442
[Abstract]
[Full text]
- Articles
Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein B
- John J.P. Kastelein, Mark K. Wedel, Brenda F. Baker, John Su, JoAnn D. Bradley, Rosie Z. Yu, Emil Chuang, Mark J. Graham, and Rosanne M. Crooke
Circulation published October 9, 2006, doi:10.1161/CIRCULATIONAHA.105.606442
[Abstract]
|
|
